Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
NEUROLOGY	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Confusion	B-Delirium
and	O
weakness	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Biopsy	O
of	O
right	O
occipital	O
lobe	O
lesion	O
History	O
of	O
Present	O
Illness:	O
___	O
is	O
an	O
___	O
man	O
with	O
recently	O
found	O
right	O
occipital	O
lobe	O
tumor	O
___	O
MRI),	O
currently	O
on	O
___	O
and	O
___,	O
who	O
presents	O
with	O
1-day	O
history	O
of	O
confusion,	B-Delirium
ataxia,	O
nausea	O
and	O
fatigue.	O
On	O
___,	O
the	O
patient	O
experienced	O
confusion,	B-Delirium
new-onset	O
left	O
facial	O
droop,	O
as	O
well	O
as	O
weakness/numbness	O
in	O
RUE/RLE.	O
He	O
was	O
taken	O
to	O
___,	O
where	O
MRI	O
revealed	O
right	O
occipital	O
lobe	O
lesion.	O
Afterwards,	O
CT	O
of	O
chest/abdomen/pelvis	O
was	O
performed,	O
and	O
it	O
revealed	O
a	O
questionable	O
nodule	O
in	O
his	O
right	O
thorax	O
between	O
the	O
___	O
and	O
3rd	O
ribs;	O
node	O
was	O
not	O
palpable	O
on	O
exam	O
at	O
this	O
time.	O
Because	O
he	O
was	O
currently	O
on	O
___,	O
biopsy	O
of	O
brain	O
lesion	O
or	O
chest	O
lesion	O
was	O
not	O
performed	O
at	O
this	O
time.	O
His	O
motor/sensory	O
symptoms	O
resolved	O
on	O
their	O
own	O
over	O
the	O
next	O
few	O
days	O
(with	O
only	O
mild	O
confusion	B-Delirium
remaining),	O
and	O
the	O
patient	O
was	O
discharged	O
from	O
___	O
on	O
___	O
with	O
instructions	O
to	O
follow	O
up.	O
Through	O
the	O
next	O
couple	O
weeks,	O
aside	O
from	O
brief	O
lapses	O
in	O
judgment	O
while	O
performing	O
everyday	O
activities,	O
the	O
patient	O
had	O
returned	O
close	O
to	O
baseline	O
and	O
able	O
to	O
walk	B-Mobile_with_aid
with	B-Mobile_with_aid
a	B-Mobile_with_aid
walker.	B-Mobile_with_aid
He	O
began	O
tapering	O
off	O
___	O
on	O
___	O
in	O
prep	O
of	O
his	O
biopsy;	O
taper	O
was	O
completed	O
on	O
___.	O
Patient	O
states	O
that,	O
per	O
cardiologist,	O
he	O
can	O
stop	O
___	O
permanently	O
from	O
here	O
on	O
out.	O
Suddenly,	O
yesterday	O
morning	O
(___),	O
the	O
patient	O
had	O
difficulty	O
getting	O
out	O
of	O
bed,	O
was	O
very	O
fatigued	O
and	O
confused,	B-Delirium
and	O
felt	O
weakness	O
in	O
his	O
left	O
arm/foot.	O
He	O
also	O
felt	O
nauseous	O
and	O
had	O
a	O
bifrontal	O
headache	O
when	O
moving	O
his	O
head	O
abruptly.	O
He	O
went	O
to	O
___,	O
where	O
CT	O
scan	O
showed	O
increased	O
mass	O
size	O
with	O
edema.	O
Patient	O
was	O
given	O
10	O
mg	O
of	O
dexamethasone,	O
and	O
then	O
sent	O
to	O
___	O
late	O
last	O
night.	O
In	O
the	O
ED,	O
initial	O
vital	O
signs	O
were:	O
Temperature	O
99.0	O
F,	O
pulse	O
68,	O
blood	O
pressure	O
107/62,	O
respiration	O
20	O
and	O
oxygen	O
saturation	O
95%	O
in	O
room	O
air.	O
Neurosurgery	O
saw	O
the	O
patient	O
in	O
ED,	O
and	O
advised	O
that	O
a	O
1-week	O
washout	O
would	O
be	O
indicated	O
before	O
they	O
would	O
be	O
able	O
to	O
perform	O
biopsy	O
of	O
the	O
occipital	O
lesion.	O
On	O
the	O
floor,	O
the	O
patient	O
feels	O
less	O
fatigued,	O
but	O
continues	O
to	O
feel	O
positional	O
headache	O
and	O
left-sided	O
weakness.	O
He	O
currently	O
denies	O
fevers,	O
chills,	O
night	O
sweats,	O
weight	B-Weight_loss
loss,	B-Weight_loss
visual	B-Visual_impairment
changes,	B-Visual_impairment
recent	O
hearing	B-Hearing_impairment
changes,	B-Hearing_impairment
changes	O
in	O
taste/smell,	O
numbness	O
or	O
tingling.	O
Review	O
of	O
systems:	O
(+)	O
Per	O
HPI	O
(-)	O
Denies	O
fever,	O
chills,	O
night	O
sweats,	O
recent	O
weight	B-Weight_loss
loss	B-Weight_loss
or	O
gain.	O
Denies	O
sinus	O
tenderness,	O
rhinorrhea	O
or	O
congestion.	O
Denies	O
cough,	O
shortness	O
of	O
breath.	O
Denies	O
chest	O
pain	O
or	O
tightness,	O
palpitations.	O
Denies	O
vomiting,	O
diarrhea,	O
constipation	B-Constipation
or	O
abdominal	O
pain.	O
No	O
recent	O
change	O
in	O
bowel	O
or	O
bladder	O
habits.	O
No	O
dysuria.	O
Denies	O
arthralgias	O
or	O
myalgias.	O
ONCOLOGY	O
TRANSFER	O
ACCEPTANCE	O
NOTE	O
Mr	O
___	O
is	O
an	O
___	O
man	O
who	O
was	O
admitted	O
via	O
ED	O
on	O
___	O
with	O
history	O
of	O
hypertension,	O
hypercholesterolemia,	O
coronary	O
artery	O
disease,	O
CABG	O
x5,	O
coronary	O
stents	O
placement	O
x6	O
in	O
___,	O
history	O
of	O
kidney	O
cancer	O
s/p	O
left	O
partial	O
nephrectomy	O
and	O
osteoarthritis	O
admitted	O
via	O
ED	O
w/	O
new	O
onset	O
dizziness,	O
worsening	O
weakness.	O
A	O
few	O
weeks	O
prior	O
to	O
this	O
he	O
had	O
some	O
right	O
and	O
left	O
upper	O
extremity	O
weakness,	O
dropping	O
object	O
as	O
well	O
as	O
numbness	O
on	O
left	O
side.	O
MRI	O
at	O
OSH	O
on	O
___	O
showed	O
left	O
occipital	O
lobe	O
mass.	O
CT	O
of	O
the	O
torso	O
there	O
showed	O
lung	O
nodule	O
between	O
___	O
and	O
3rd	O
rib.	O
Was	O
on	O
___	O
at	O
the	O
time	O
so	O
was	O
not	O
biopsied.	O
He	O
was	O
discharged	O
in	O
late	O
___	O
with	O
instructions	O
for	O
follow	O
up.	O
He	O
later	O
did	O
poorly	O
at	O
home.	O
He	O
had	O
new	O
lapses	O
in	O
attention	O
then	O
developed	O
ataxia	O
and	O
progressive	O
left-sided	O
weakness.	O
Returned	O
to	O
OSH,	O
mass	O
bigger	O
on	O
CT	O
head	O
and	O
had	O
edema,	O
he	O
was	O
transferred	O
to	O
___.	O
He	O
was	O
seen	O
by	O
the	O
neurosurgery	O
service	O
in	O
ED,	O
he	O
had	O
been	O
off	O
___	O
and	O
___	O
for	O
planned	O
biopsy.	O
Repeat	O
MRI	O
brain	O
on	O
___	O
showed	O
increased	O
now	O
5.0	O
cm	O
x	O
4.1	O
cm	O
x	O
3.0	O
cm	O
homogeneously	O
enhancing	O
lesion	O
in	O
the	O
right	O
posterior	O
parietal,	O
occipital	O
and	O
medial	O
temporal	O
lobes	O
extending	O
into	O
the	O
right	O
side	O
of	O
the	O
splenium	O
of	O
the	O
corpus	O
callosum	O
along	O
with	O
a	O
few	O
satellite	O
nodules	O
and	O
moderate	O
surrounding	O
vasogenic	O
edema	O
and	O
mass	O
effect	O
on	O
the	O
right	O
lateral	O
ventricle.	O
He	O
did	O
undergo	O
a	O
right	O
occipital	O
stereotactic	O
brain	O
biopsy	O
on	O
___.	O
Preliminary	O
pathology	O
showed	O
CNS	O
lymphoma.	O
He	O
was	O
treated	O
with	O
dexamethasone	O
and	O
was	O
transferred	O
to	O
___	O
today	O
to	O
initiate	O
treatment.	O
Patient	O
stated	O
overall	O
he	O
has	O
improved	O
walking,	O
no	O
difficulty	O
with	O
balance	O
currently.	O
Also,	O
he	O
had	O
trouble	O
with	O
left-sided	O
peripheral	B-Visual_impairment
vision	B-Visual_impairment
that	O
is	O
now	O
improved.	O
He	O
is	O
also	O
no	O
longer	O
dropping	O
objects.	O
Past	O
Medical	O
History:	O
-	O
CABG	O
(___)	O
-	O
Coronary	O
stents	O
in	O
___	O
-	O
Hypertension	O
-	O
Kidney	O
cancer	O
s/p	O
left	O
partial	O
nephrectomy;	O
no	O
adjuvant	O
chemotherapy	O
or	O
radiation	O
-	O
Osteoarthritis	O
-	O
Bilateral	O
knee	O
replacement	O
-	O
Left	O
hip	O
replacement	O
Social	O
History:	O
___	O
Family	O
History:	O
His	O
mother	O
died	O
of	O
heart	O
failure	O
while	O
his	O
father	O
died	O
of	O
cerebral	B-Intracranial_haemorrhage
hemorrhage	B-Intracranial_haemorrhage
after	O
a	O
motor	O
vehicle	O
accident.	O
His	O
brother	O
died	O
after	O
a	O
heart	O
transplant	O
after	O
a	O
myocardial	O
infarction.	O
his	O
sister	O
is	O
alive	O
with	O
breast	O
cancer	O
and	O
ovarian	O
cancer	O
in	O
remission.	O
He	O
has	O
3	O
sons;	O
they	O
are	O
all	O
healthy.	O
Physical	O
Exam:	O
EXAMINATION	O
ON	O
ADMISSION:	O
=====================	O
VITAL	O
SIGNS:	O
Temperature	O
98.4	O
F,	O
blood	O
pressure	O
139/58,	O
pulse	O
51,	O
respiration	O
20	O
and	O
oxygen	O
saturation	O
98%	O
in	O
room	O
air	O
GENERAL:	O
No	O
acute	O
distress,	O
alert	O
and	O
oriented	B-Delirium
x	B-Delirium
3	B-Delirium
HEENT:	O
MMM,	O
oropharynx	O
clear	O
NECK:	O
Supple,	O
JVP	O
not	O
elevated,	O
no	O
LAD	O
LUNGS:	O
Clear	O
to	O
auscultation	O
bilaterally,	O
no	O
wheezes,	O
rales,	O
rhonchi	O
CARDIOVASCULAR:	O
Irregular	O
rhythm,	O
no	O
murmurs/rubs/gallops	O
ABDOMEN:	O
Soft,	O
non-tender,	O
non-distended,	O
bowel	O
sounds	O
present,	O
no	O
rebound	O
tenderness	O
or	O
guarding,	O
no	O
organomegaly	O
EXTREMITIES:	O
Warm,	O
well	O
perfused,	O
2+	O
radial	O
and	O
DP	O
pulses	O
bilaterally,	O
no	O
clubbing,	O
cyanosis	O
or	O
edema	O
SKIN:	O
moist,	O
3	O
cm	O
raised	O
plaque	O
on	O
R	O
forehead	O
(chronic)	O
NEUROLOGICAL	O
EXAMINATION:	O
CN	O
___	O
intact,	O
can't	O
discriminate	O
between	O
left/right	O
sound	O
because	O
of	O
bilateral	O
hearing	B-Hearing_impairment
aids,	B-Hearing_impairment
___	O
strength	O
in	O
left	O
handgrip/biceps/hip	O
flexors	O
but	O
full	O
strenth	O
otherwise;	O
sensation	O
intact	O
bilaterally;	O
finger-to-nose	O
test	O
worse	O
on	O
left	O
side	O
EXAMINATION	O
ON	O
DISCHARGE:	O
======================	O
VITAL	O
SIGNS:	O
Temerpature	O
98.3	O
F,	O
blood	O
pressure	O
142/60,	O
pulse	O
70,	O
respiration	O
18	O
and	O
oxygen	O
saturation	O
98%	O
in	O
room	O
air	O
GENERAL:	O
Elderly	O
man	O
seated	O
in	O
chair,	O
NAD.	O
HEENT:	O
PERRL.	O
MMM.	O
no	O
LAD.	O
no	O
JVD.	O
neck	O
supple.	O
Stapled	O
incision	O
on	O
R	O
posterior	O
head	O
with	O
dressing	O
with	O
dried	O
blood.	O
CARDIOVASCULAR:	O
RRR	O
S1/S2	O
normal.	O
no	O
murmurs/gallops/rubs.	O
PULMONARY:	O
CTAB	O
no	O
w/r/r	O
ABDOMEN:	O
BS+,	O
soft,	O
NT,	O
no	O
rebound/guarding	O
EXTREMITIES:	O
Wwp,	O
no	O
edema	O
SKIN:	O
no	O
rashes	O
or	O
bruising	O
NEUROLOGICAL	O
EXAMINATION:	O
CNs	O
II-XII	O
intact	O
except	O
for	O
L	O
peripheral	O
visual	B-Visual_impairment
field	B-Visual_impairment
deficit.	B-Visual_impairment
___	O
strength	O
in	O
bilateral	O
UE	O
throughout.	O
___	O
left	O
___	O
strength	O
compared	O
to	O
___	O
right	O
___	O
strength	O
throughout.	O
No	O
gross	O
sensory	O
deficits.	O
finger	O
to	O
nose	O
intact.	O
Gait	O
slightly	O
ataxic	O
but	O
at	O
his	O
baseline.	O
Pertinent	O
Results:	O
PERTINENT	O
RESULTS	O
ON	O
ADMISSION:	O
==================================	O
___	O
10:25PM	O
BLOOD	O
WBC-9.4	O
RBC-3.99*	O
Hgb-13.1*	O
Hct-38.1*	O
MCV-96	O
MCH-32.8*	O
MCHC-34.3	O
RDW-13.6	O
Plt	O
___	O
___	O
10:25PM	O
BLOOD	O
Neuts-92.2*	O
Lymphs-4.5*	O
Monos-2.7	O
Eos-0.5	O
Baso-0.1	O
___	O
10:25PM	O
BLOOD	O
Glucose-114*	O
UreaN-32*	O
Creat-1.4*	O
Na-134	O
K-4.5	O
Cl-98	O
HCO3-25	O
AnGap-16	O
PERTINENT	O
RESULTS	O
ON	O
DISCHARGE:	O
==================================	O
___	O
05:41AM	O
BLOOD	O
WBC-6.4	O
RBC-3.70*	O
Hgb-12.0*	O
Hct-35.0*	O
MCV-95	O
MCH-32.4*	O
MCHC-34.3	O
RDW-13.5	O
Plt	O
Ct-89*	O
___	O
05:41AM	O
BLOOD	O
Glucose-113*	O
UreaN-35*	O
Creat-1.8*	O
Na-137	O
K-3.3	O
Cl-87*	O
HCO3-41*	O
AnGap-12	O
___	O
05:41AM	O
BLOOD	O
ALT-75*	O
AST-28	O
AlkPhos-47	O
TotBili-0.9	O
___	O
05:41AM	O
BLOOD	O
Calcium-8.6	O
Phos-3.0	O
Mg-1.8	O
___	O
05:41AM	O
BLOOD	O
mthotrx-0.05	O
___	O
06:37AM	O
BLOOD	O
mthotrx-0.10	O
___	O
05:00AM	O
BLOOD	O
mthotrx-0.26	O
___	O
06:10AM	O
BLOOD	O
mthotrx-0.99	O
___	O
05:30PM	O
BLOOD	O
mthotrx-4.2	O
MICROBIOLOGY:	O
==================================	O
Urine	O
culture	O
(___):	O
negative	O
CARDIOLOGY:	O
==================================	O
ECHO	O
(___):	O
The	O
left	O
atrium	O
is	O
mildly	O
dilated.	O
The	O
right	O
atrium	O
is	O
moderately	O
dilated.	O
No	O
atrial	O
septal	O
defect	O
is	O
seen	O
by	O
2D	O
or	O
color	O
Doppler.	O
The	O
estimated	O
right	O
atrial	O
pressure	O
is	O
___	O
mmHg.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
normal	O
cavity	O
size.	O
Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
mildly	O
depressed	O
(LVEF=	O
50	O
%).	O
There	O
is	O
considerable	O
beat-to-beat	O
variability	O
of	O
the	O
left	O
ventricular	O
ejection	O
fraction	O
due	O
to	O
an	O
irregular	O
rhythm/premature	O
beats.	O
Tissue	O
Doppler	O
imaging	O
suggests	O
a	O
normal	O
left	O
ventricular	O
filling	O
pressure	O
(PCWP<12mmHg).	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
ascending	O
aorta	O
is	O
mildly	O
dilated.	O
The	O
aortic	O
valve	O
leaflets	O
are	O
moderately	O
thickened.	O
There	O
is	O
no	O
aortic	O
valve	O
stenosis.	O
Mild	O
(1+)	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
Trivial	O
mitral	O
regurgitation	O
is	O
seen.	O
There	O
is	O
mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
a	O
trivial/physiologic	O
pericardial	O
effusion.	O
There	O
is	O
an	O
anterior	O
space	O
which	O
most	O
likely	O
represents	O
a	O
prominent	O
fat	O
pad.	O
IMPRESSION:	O
Mildly	O
reduced	O
global	O
left	O
ventricular	O
systolic	O
function	O
in	O
the	O
setting	O
of	O
beat-to-beat	O
variability	O
secondary	O
to	O
arrhythmia.	O
Biarial	O
enlargement.	O
Mild	O
symmetric	O
left	O
ventricular	O
hypertrophy.	O
Mildly	O
dilated	O
ascending	O
aorta.	O
Mild	O
mitral	O
and	O
tricuspid	O
regurgitation.	O
Mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
PATHOLOGY:	O
==================================	O
-	O
Brain/Meninges	O
for	O
tumor	O
(___):	O
CNS	O
Lymphoma	O
RADIOLOGY:	O
==================================	O
-	O
CHEST	O
(PORTABLE	O
AP)	O
(___):	O
No	O
previous	O
images.	O
There	O
is	O
enlargement	O
of	O
the	O
cardiac	O
silhouette	O
without	O
definite	O
vascular	O
congestion,	O
with	O
surgical	O
clips	O
from	O
previous	O
CABG	O
procedure.	O
No	O
evidence	O
of	O
acute	O
focal	O
pneumonia.	B-Lower_respiratory_tract_infection
There	O
is	O
leftward	O
displacement	O
of	O
the	O
lower	O
cervical	O
trachea,	O
suggesting	O
a	O
right	O
thyroid	O
mass.	O
-	O
Thyroid	O
US	O
(___):	O
Solitary	O
dominant	O
right	O
thyroid	O
nodule.	O
An	O
ultrasound-guided	O
FNA	O
can	O
be	O
performed	O
on	O
a	O
nonurgent	O
basis.	O
-	O
MR	O
HEAD	O
W	O
&	O
W/O	O
CONTRAS	O
(___):	O
1.	O
A	O
5.0	O
x	O
4.1	O
x3.0	O
cm	O
homogeneously	O
enhancing	O
lesion	O
in	O
the	O
right	O
posterior	O
parietal,	O
occipital	O
and	O
medial	O
temporal	O
lobes	O
extending	O
into	O
the	O
right	O
side	O
of	O
the	O
splenium	O
of	O
the	O
corpus	O
callosum	O
along	O
with	O
a	O
few	O
satellite	O
nodules	O
and	O
moderate	O
surrounding	O
vasogenic	O
edema	O
and	O
mass	O
effect	O
on	O
the	O
right	O
lateral	O
ventricle,	O
increased	O
since	O
the	O
recent	O
study	O
of	O
___	O
Differential	O
diagnosis	O
includes	O
lymphoma,	O
glial	O
tumor,	O
metastasis,	O
etc.	O
Inflammatory,	O
infective,	O
autoimmune/demyelinating	O
etiologies	O
are	O
less	O
likely	O
given	O
the	O
appearance,	O
though	O
cannot	O
be	O
completely	O
excluded.	O
Correlate	O
clinically	O
and	O
with	O
labs.	O
As	O
per	O
the	O
___	O
clinical	O
notes,	O
biopsy	O
is	O
being	O
planned;	O
follow-up	O
as	O
needed	O
2.	O
A	O
small	O
1.7	O
cm	O
enhancing	O
nodule	O
in	O
the	O
right	O
frontal	O
scalp	O
soft	O
tissues	O
-	O
etiology	O
uncertain,	O
attention	O
on	O
followup	O
3.	O
Fluid	O
in	O
the	O
left	O
maxillary	O
sinus	O
and	O
left	O
mastoid	O
air	O
cells.	O
Correlate	O
clinically	O
with	O
ENT	O
examination	O
for	O
obstructive	O
etiology	O
appear	O
-	O
CT	O
STEREOTAXIS	O
W/	O
CONTRAST	O
(___):	O
1.	O
Irregularly	O
enhancing	O
lesion	O
centered	O
in	O
the	O
right	O
occipital	O
and	O
parietal	O
lobes,	O
abutting	O
the	O
right	O
lateral	O
ventricle,	O
is	O
again	O
demonstrated	O
for	O
surgical	O
planning.	O
2.	O
Nonspecific	O
soft	O
tissue	O
nodule	O
is	O
again	O
seen	O
in	O
the	O
right	O
frontal	O
scalp.	O
-	O
CT	B-Intracranial_haemorrhage
HEAD	B-Intracranial_haemorrhage
W/O	O
CONTRAST	O
(___):	O
Expected	O
appearance	O
status	O
post	O
right	O
occipital	O
mass	O
biopsy.	O
Only	O
a	O
small	O
focus	O
of	O
hemorrhage	B-Intracranial_haemorrhage
is	O
identified	O
within	O
the	O
lesion.	O
Brief	O
Hospital	O
Course:	O
___	O
is	O
an	O
___	O
man	O
with	O
newly	O
diagnosed	O
right	O
occipital	O
CNS	O
lymphoma	O
(___),	O
who	O
presents	O
with	O
1-day	O
history	O
of	O
fatigue,	O
confusion,	B-Delirium
and	O
left-sided	O
weakness.	O
1.	O
Right	O
Occipital	O
CNS	O
Lymphoma:	O
As	O
shown	O
by	O
CT	O
from	O
OSH,	O
tumor	O
has	O
progressed	O
in	O
2	O
week	O
span.	O
Patient	O
had	O
new	O
symptoms	O
of	O
mild	O
LUE/LLE	O
weakness	O
and	O
partial	O
left-sided	O
hemianopsia.	O
MRI	O
w/contrast	O
performed	O
on	O
___	O
revealed	O
a	O
5.0	O
x	O
4.1	O
x	O
3.0	O
cm	O
homogeneously	O
enhancing	O
lesion	O
in	O
the	O
right	O
posterior	O
parietal,	O
occipital	O
and	O
medial	O
temporal	O
lobes	O
extending	O
into	O
the	O
right	O
side	O
of	O
the	O
splenium	O
of	O
the	O
corpus	O
callosum	O
along	O
with	O
a	O
few	O
satellite	O
nodules	O
and	O
moderate	O
surrounding	O
vasogenic	O
edema	O
and	O
mass	O
effect	O
on	O
the	O
right	O
lateral	O
ventricle,	O
increased	O
since	O
the	O
recent	O
study	O
of	O
___.	O
In	O
addition,	O
a	O
small	O
1.7	O
cm	O
enhancing	O
nodule	O
in	O
the	O
right	O
frontal	O
scalp	O
soft	O
tissues	O
was	O
seen.	O
Neurosurgery	O
performed	O
CT-guided	O
biopsy	O
of	O
the	O
right-sided	O
occipital	O
lesion	O
on	O
___.	O
Patient	O
did	O
well	O
during	O
procedure,	O
no	O
complications,	O
frozen	O
specimen	O
looked	O
like	O
lymphoma.	O
Patient	O
was	O
started	O
on	O
Decadron	O
4Q6	O
afterwards.	O
Head	B-Intracranial_haemorrhage
CT	B-Intracranial_haemorrhage
postop	O
showed	O
"Expected	O
appearance	O
status	O
post	O
right	O
occipital	O
mass	O
biopsy.	O
Only	O
a	O
small	O
focus	O
of	O
hemorrhage	B-Intracranial_haemorrhage
is	O
identified	O
within	O
the	O
lesion."	O
After	O
procedure,	O
SBP	O
was	O
kept	O
under	O
140.	O
___	O
restarted	O
24h	O
postoperatively.	O
On	O
___,	O
patient	O
was	O
transferred	O
to	O
Neuro-Oncology	O
service	O
(Dr.	O
___	O
for	O
chemotherapy.	O
He	O
successfully	O
underwent	O
his	O
first	O
cycle	O
of	O
methotrexate	O
therapy	O
under	O
Dr.	O
___	O
care	O
as	O
an	O
inpatient.	O
He	O
tolerated	O
the	O
therapy	O
well	O
with	O
very	O
minimal	O
side	O
effects.	O
He	O
was	O
evaluated	O
by	O
___	O
and	O
was	O
discharged	O
home	O
to	O
return	O
the	O
following	O
week	O
for	O
his	O
second	O
cycle.	O
2.	O
Acute	O
Kidney	O
Insufficiency:	O
Patient	O
underwent	O
his	O
cycle	O
of	O
methotrexate	O
chemotherapy	O
as	O
an	O
inpatient.	O
He	O
was	O
hydrated	O
with	O
a	O
bicarbonate	O
infusion	O
continuously	O
to	O
alkalinize	O
his	O
urine	O
for	O
his	O
methotrexate	O
therapy.	O
His	O
initial	O
creatinine	O
of	O
1.2	O
on	O
admission	O
was	O
elevated	O
to	O
1.4	O
the	O
day	O
after	O
receiving	O
his	O
first	O
dose	O
of	O
methotrexate.	O
It	O
uptrended	O
and	O
stabilized	O
at	O
1.8	O
for	O
three	O
days	O
on	O
day	O
of	O
discharge.	O
A	O
calculate	O
FeNA	O
was	O
18%,	O
indicating	O
intrinsic	O
renal	O
injury	O
likely	O
due	O
to	O
methotrexate.	O
His	O
urine	O
output	O
remained	O
sufficient	O
given	O
he	O
was	O
adequately	O
hydrated	O
with	O
IV	O
fluids	O
and	O
his	O
own	O
po	O
intake	O
was	O
sufficient.	O
It	O
was	O
expected	O
that	O
his	O
Cr	O
would	O
normalize	O
back	O
to	O
baseline	O
once	O
his	O
methotrexate	O
cycle	O
ended	O
and	O
he	O
was	O
encouraged	O
to	O
maintain	O
adequate	O
hydration	O
at	O
home.	O
His	O
chemistry	O
panel	O
will	O
be	O
monitored	O
as	O
an	O
outpatient	O
on	O
followup.	O
3.	O
Hyponatremia:	O
Na=134	O
(___)	O
->	O
133	O
(___)	O
->	O
130	O
(___)	O
->	O
134	O
->	O
136.	O
Given	O
intracranial	O
pathology,	O
SIADH	O
vs	O
cerebral	O
salt	O
wasting.	O
4.	O
Coronary	O
Artery	O
Disease:	O
History	O
of	O
CABG	O
and	O
stents	O
(___).	O
___	O
discontinued	O
as	O
per	O
cardiologist	O
(last	O
dose	O
on	O
___.	O
5.	O
Thyroid	O
Nodule:	O
Chest	O
X-ray	O
from	O
___	O
showed	O
leftward	O
displacement	O
of	O
trachea,	O
suggesting	O
right-sided	O
thyroid	O
mass.	O
Confirmed	O
by	O
thyroid	O
U/S,	O
which	O
revealed	O
solitary	O
dominant	O
right	O
thyroid	O
nodule.	O
TSH=2.0.	O
Ultrasound-guided	O
FNA	O
to	O
be	O
performed	O
as	O
outpatient.	O
6.	O
Hypertension:	O
Continue	O
atenolol	O
and	O
lisinopril.	O
7.	O
Elevated	O
Cratinine	O
(Improved):	O
Cr	O
1.7	O
recently	O
from	O
outside	O
hospital	O
but	O
no	O
other	O
records	O
in	O
OMR.	O
Appears	O
chronic,	O
especially	O
given	O
history	O
of	O
partial	O
nephrectomy.	O
As	O
of	O
___,	O
Cr=1.2.	O
Patient	O
was	O
pre-hydrated	O
before	O
biopsy.	O
-	O
Trend	O
Creatinine	O
TRANSITIONAL	O
CARE	O
ISSUES:	O
============================	O
-	O
Management	O
of	O
malignancy	O
as	O
dictated	O
by	O
biopsy	O
-	O
Follow-up	O
of	O
right-sided	O
frontal	O
lesion	O
-	O
Ultrasound-guided	O
FNA	O
as	O
outpatient	O
-	O
Restart	O
aspirin	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Atenolol	O
25	O
mg	O
PO	O
DAILY	O
2.	O
alfuzosin	O
10	O
mg	O
oral	O
every	O
morning	O
3.	O
Ezetimibe	O
10	O
mg	O
PO	O
DAILY	O
4.	O
Lansoprazole	O
Oral	O
Disintegrating	O
Tab	O
15	O
mg	O
PO	O
DAILY	O
5.	O
Lisinopril	O
5	O
mg	O
PO	O
DAILY	O
6.	O
Hydrochlorothiazide	O
12.5	O
mg	O
PO	O
DAILY	O
7.	O
Pravastatin	O
40	O
mg	O
PO	O
DAILY	O
8.	O
Diclofenac	O
Sodium	O
___	O
75	O
mg	O
PO	O
BID	O
9.	O
Glucosamine	O
(glucosamine	O
sulfate)	O
1500	O
mg	O
oral	O
bid	O
10.	O
Chondroitin	O
Sulfate	O
(chondroitin	O
sulf	O
A	O
sod	O
(bulk);<br>chondroitin	O
sulfate	O
A)	O
1200	O
mg	O
oral	O
bid	O
11.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
12.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
13.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
Q48H	O
Discharge	O
Medications:	O
1.	O
Outpatient	O
Lab	O
Work	O
Please	O
draw	O
a	O
CBC	O
w/diff	O
and	O
chem	O
panel	O
on	O
___.	O
Please	O
fax	O
results	O
to	O
Dr.	O
___.	O
ICD9	O
200.5	O
2.	O
Atenolol	O
25	O
mg	O
PO	O
DAILY	O
3.	O
Ezetimibe	O
10	O
mg	O
PO	O
DAILY	O
4.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
Q48H	O
5.	O
Hydrochlorothiazide	O
12.5	O
mg	O
PO	O
DAILY	O
6.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
7.	O
Pravastatin	O
40	O
mg	O
PO	O
DAILY	O
8.	O
Dexamethasone	O
4	O
mg	O
PO	O
Q12H	O
Taper	O
to	O
be	O
set	O
by	O
Neurooncology	O
on	O
follow-up	O
visit.	O
RX	O
*dexamethasone	O
4	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*60	O
Tablet	O
Refills:*0	O
9.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
RX	O
*docusate	O
sodium	O
[Colace]	O
100	O
mg	O
1	O
capsule(s)	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*30	O
Capsule	O
Refills:*0	O
10.	O
OxycoDONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
Q4H:PRN	O
Pain	O
RX	O
*oxycodone	O
5	O
mg	O
1	O
capsule(s)	O
by	O
mouth	O
every	O
six	O
(6)	O
hours	O
Disp	O
#*10	O
Capsule	O
Refills:*0	O
11.	O
Senna	O
8.6	O
mg	O
PO	O
BID	O
RX	O
*sennosides	O
[senna]	O
8.6	O
mg	O
1	O
tablet	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*30	O
Capsule	O
Refills:*0	O
12.	O
alfuzosin	O
10	O
mg	O
oral	O
every	O
morning	O
13.	O
Chondroitin	O
Sulfate	O
(chondroitin	O
sulf	O
A	O
sod	O
(bulk);<br>chondroitin	O
sulfate	O
A)	O
1200	O
mg	O
oral	O
bid	O
14.	O
Glucosamine	O
(glucosamine	O
sulfate)	O
1500	O
mg	O
oral	O
bid	O
15.	O
Lansoprazole	O
Oral	O
Disintegrating	O
Tab	O
15	O
mg	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary:	O
-	O
Right	O
Occipital	O
CNS	O
Lymphoma	O
-	O
Thyroid	O
nodule	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
___.	O
You	O
were	O
hospitalized	O
for	O
weakness	O
and	O
dizziness.	O
An	O
MRI	O
of	O
your	O
brain	O
revealed	O
a	O
mass.	O
Our	O
neurosurgeons	O
biopsied	O
this	O
mass,	O
and	O
it	O
ended	O
up	O
being	O
lymphoma,	O
a	O
type	O
of	O
cancer.	O
You	O
were	O
started	O
on	O
chemotherapy	O
(a	O
drug	O
called	O
Methotrexate).	O
You	O
tolerated	O
the	O
chemotherapy	O
very	O
well	O
with	O
minimal	O
side	O
effects.	O
You	O
were	O
also	O
treated	O
with	O
steroids,	O
which	O
you	O
will	O
continue	O
after	O
discharge.	O
You	O
will	O
have	O
bloodwork	O
drawn	O
on	O
___,	O
which	O
will	O
help	O
plan	O
your	O
next	O
round	O
of	O
chemotherapy.	O
Your	O
next	O
cycle	O
of	O
chemo	O
will	O
begin	O
on	O
___.	O
The	O
___	O
clinic	O
will	O
contact	O
you	O
to	O
schedule	O
your	O
next	O
cycle.	O
If	O
you	O
do	O
not	O
hear	O
from	O
them	O
within	O
the	O
next	O
___	O
days,	O
you	O
should	O
call	O
the	O
clinic	O
at	O
___.	O
Thank	O
you,	O
___,	O
MD	O
___	O
Followup	O
Instructions:	O
___	O

